Literature DB >> 20531279

Alpha1 and beta1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells.

Satyanarayana Rentala1, Prameela Devi Yalavarthy, Lakshmi Narasu Mangamoori.   

Abstract

CD133(+) prostate cancer stem cells (PCSCs) have recently been identified in human prostate cancer tissues. The present study reports the integrin profile of prostate cancer progenitor cells and the role of alpha(1) and beta(1) integrins in the homing and differentiation of PCSCs in vitro. PCSCs were isolated from the tissue specimens of patients with prostate cancer and the expression of surface integrins and adhesion patterns were determined. Our analysis of the expression of surface integrins and their adhesion patterns of prostate cancer stem cells derived from prostate cancer tissues revealed that the levels of beta(1) and alpha(2)beta(1) integrins were significantly higher (P < 0.05) than those of the other integrins. By contrast, peripheral blood-derived CD133(+) cells from prostate cancer patients showed a high level of expression (P < 0.01) of alpha(2)beta(1), alpha(v)beta(3), alpha(v)beta(5), beta(1) and alpha(1) integrins and a minimal expression of alpha(4)beta(1) integrins. Moreover, CD133(+) cells derived from both prostate cancer tissues and peripheral blood exhibited an increased degree of attachment to extracellular matrix proteins (P < 0.001) and a high expression level of alpha(2)beta(1) integrin. In vitro experiments using blocking antibodies indicated that alpha(1) and beta(1) integrins have a role in the homing and differentiation of PCSCs. This is the first report to suggest the importance of integrins in mediating the homing and differentiation of PCSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531279      PMCID: PMC3739363          DOI: 10.1038/aja.2010.20

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  21 in total

Review 1.  Cytoskeleton and integrin-mediated adhesion signaling in human CD34+ hemopoietic progenitor cells.

Authors:  J P Lévesque; P J Simmons
Journal:  Exp Hematol       Date:  1999-04       Impact factor: 3.084

2.  Oct-3/4 is a dose-dependent oncogenic fate determinant.

Authors:  Sharon Gidekel; Galina Pizov; Yehudit Bergman; Eli Pikarsky
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

3.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

4.  Examination of POU homeobox gene expression in human breast cancer cells.

Authors:  T Jin; D R Branch; X Zhang; S Qi; B Youngson; P E Goss
Journal:  Int J Cancer       Date:  1999-03-31       Impact factor: 7.396

5.  Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium.

Authors:  E J Robinson; D E Neal; A T Collins
Journal:  Prostate       Date:  1998-11-01       Impact factor: 4.104

6.  Smooth muscle progenitor cells in human blood.

Authors:  David Simper; Paul G Stalboerger; Carmelo J Panetta; Shaohua Wang; Noel M Caplice
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

7.  Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression.

Authors:  A T Collins; F K Habib; N J Maitland; D E Neal
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

8.  Human embryonic genes re-expressed in cancer cells.

Authors:  M Monk; C Holding
Journal:  Oncogene       Date:  2001-12-06       Impact factor: 9.867

9.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 10.  Prostate cancer stem cells.

Authors:  S H Lang; F M Frame; A T Collins
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

View more
  10 in total

Review 1.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

Review 2.  MicroRNAs targeting prostate cancer stem cells.

Authors:  Yu-Xiang Fang; Yun-Li Chang; Wei-Qiang Gao
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

3.  mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.

Authors:  Federica Finetti; Erika Terzuoli; Antonio Giachetti; Raffaella Santi; Donata Villari; Hiromi Hanaka; Olof Radmark; Marina Ziche; Sandra Donnini
Journal:  Endocr Relat Cancer       Date:  2015-06-25       Impact factor: 5.678

4.  Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.

Authors:  Igor Tsaur; Lukasz Hudak; Jasmina Makarević; Eva Juengel; Jens Mani; Hendrik Borgmann; Kilian M Gust; David Schilling; Georg Bartsch; Karen Nelson; Axel Haferkamp; Roman A Blaheta
Journal:  J Cell Mol Med       Date:  2015-03-26       Impact factor: 5.310

5.  CW-EPR studies revealed different motional properties and oligomeric states of the integrin β1a transmembrane domain in detergent micelles or liposomes.

Authors:  Lu Yu; Wei Wang; Shenglong Ling; Sanling Liu; Liang Xiao; Yanlong Xin; Chaohua Lai; Ying Xiong; Longhua Zhang; Changlin Tian
Journal:  Sci Rep       Date:  2015-01-19       Impact factor: 4.379

6.  Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin.

Authors:  Wei-Ching Chen; Hui-Ping Hsu; Chung-Yen Li; Ya-Ju Yang; Yu-Hsuan Hung; Chien-Yu Cho; Chih-Yang Wang; Tzu-Yang Weng; Ming-Derg Lai
Journal:  Int J Oncol       Date:  2016-09-15       Impact factor: 5.650

7.  Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.

Authors:  Shiwu Wu; Lan Yu; Danna Wang; Lei Zhou; Zenong Cheng; Damin Chai; Li Ma; Yisheng Tao
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

8.  Integrin α1 has a long helix, extending from the transmembrane region to the cytoplasmic tail in detergent micelles.

Authors:  Chaohua Lai; Xiaoxi Liu; Changlin Tian; Fangming Wu
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

Review 9.  Prostate Cancer Stem Cells: Research Advances.

Authors:  Dagmara Jaworska; Wojciech Król; Ewelina Szliszka
Journal:  Int J Mol Sci       Date:  2015-11-17       Impact factor: 5.923

10.  Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.

Authors:  Chris Shidal; Numan Al-Rayyan; Kavitha Yaddanapudi; Keith R Davis
Journal:  Oncotarget       Date:  2016-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.